Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.290
+0.030 (2.38%)
Nov 21, 2024, 11:09 AM EST - Market open
BCLI's stock price has decreased by -53.76% in the past year and price targets may not have had time to catch up.
BCLI Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$30.00
Upside
+2,225.58%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +2,225.58% | Jul 11, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 28, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $75 → $150 | Strong Buy | Maintains | $75 → $150 | +11,527.91% | Mar 31, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 5, 2021 |
| Maxim Group | Maxim Group | Strong Buy Maintains $120 → $135 | Strong Buy | Maintains | $120 → $135 | +10,365.12% | Aug 17, 2017 |